Z-Endoxifen Clinical Trial for Breast Cancer

ClinicalTrials.gov identifier: NCT05607004

This Phase 2 clinical study evaluates a (Z)-endoxifen-based neoadjuvant treatment in premenopausal women with ER-positive, HER2-negative breast cancer.

Study availability and enrollment status may change. A California Research Institute coordinator can confirm current local availability and explain the screening process.

Request study information